Detection of HCV antigens as a unique tool to identify HCV infection of liver graft:: Relevance to the management of recurrent post-liver transplant hepatitis C

被引：0
|
作者：
Grassi, A.
Susca, M.
Quarneti, C.
Ravaioli, M.
Bianchini, E.
D'Errico, A.
Tame, M.
Piscaglia, E.
Andreone, P.
Grazi, G. L.
Galli, S.
Zauli, D.
Pinna, A. D.
Bianchi, F. B.
Ballardini, G.
机构：
[1] St Orsola Marcello Malpighi Hosp, Bologna Liver Transplant Program, Bologna, Italy
[2] Univ Bologna, Bologna, Italy
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80168-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
167
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [31] CLINICAL OUTCOMES OF OCCULT HEPATITIS C INFECTION IN A POST-LIVER TRANSPLANT POPULATION
    Kahn, Jeffrey
    Bang, Bo-Ram
    Cook, Linda
    Lee, Brian T.
    Harper, Tammy
    Kim, Brian
    Emamaullee, Juliet
    Genyk, Yuri
    Chopra, Shefali
    Kanel, Gary
    Jerome, Keith
    Saito, Takeshi
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1103 - S1103
  • [32] Developing therapies to treat hepatitis C infection in post-liver transplant recipients
    McCarty, Thomas R.
    Lim, Joseph K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 165 - 174
  • [33] SIROLIMUS-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH IMPROVED SUSTAINED VIROLOGIC RESPONSE(SVR) TO ANTIVIRAL TREATMENT FOR PATIENTS WITH RECURRENT HEPATITIS C (HCV)INFECTION POST-LIVER TRANSPLANT(LT)
    Asthana, Sonal
    Burak, Kelly W.
    Bailey, Jennifer
    Myers, Robert P.
    Meeberg, Glenda
    Mason, Andrew L.
    Bain, Vincent G.
    Kneteman, Norman M.
    [J]. HEPATOLOGY, 2011, 54 : 451A - 452A
  • [34] IMPACT OF HCV-INFECTION ON GLOMERULAR FILTRATION RATE (GFR) IN THE FIRST YEAR POST-LIVER TRANSPLANT
    Asay, M. M.
    Mangus, R. S.
    Fridell, J. A.
    Lutz, A. J.
    Tector, A. J.
    Vianna, R. M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 184 - 184
  • [35] Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
    Rishi Arora
    Michelle T Martin
    Justin Boike
    Sonalie Patel
    [J]. World Journal of Hepatology, 2023, (02) : 318 - 320
  • [36] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [37] RECURRENT HEPATITIS-C (HCV) IN LIVER ALLOGRAFTS - HISTOLOGY AND HCV-RNA IN LIVER-TISSUE
    ROBIOU, C
    KHETTRY, U
    LEWIS, D
    MECKLER, J
    LODA, M
    [J]. LABORATORY INVESTIGATION, 1995, 72 (01) : A133 - A133
  • [38] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [39] DIAGNOSIS OF HEPATITIS-C VIRAL (HCV) INFECTION IN LIVER-TRANSPLANT RECIPIENTS
    DONEGAN, E
    WRIGHT, TL
    KIM, M
    ROBERTS, J
    ASCHER, N
    WILBER, J
    CHAN, C
    QAUN, S
    DETMER, J
    POLITO, A
    URDEA, M
    [J]. HEPATOLOGY, 1992, 16 (04) : A70 - A70
  • [40] HCV GENOTYPES, POST TRANSPLANT HEPATITIS (PTH) AND HCV RECURRENCE AFTER LIVER-TRANSPLANTATION
    BELLI, LS
    SILINI, E
    ALBERTI, A
    BELLATI, G
    FESCE, E
    GELOSA, F
    ASTI, L
    RONDINARA, GF
    DECARLIS, L
    BELLI, L
    IDEO, G
    [J]. HEPATOLOGY, 1994, 20 (04) : A131 - A131
12345